Outcome measures including raw scores and adjusted mean differences from analysis of covariance analysis
| Baseline | Follow-up | ||||||
|---|---|---|---|---|---|---|---|
| Outcome measure | Control group Mean (SD) | Intervention group Mean (SD) | Control group Mean (SD) | Intervention group Mean (SD) | Scale range | Adjusted mean difference between groups at follow-up (95% CI) | Effect size (95% CI) |
| Primary outcome measure | |||||||
| Barthel index | 17.8 (3.4) n=32 | 17.8 (2.4) n=27 | 17.7 (3.0) n=22 | 18.2 (2.9) n=21 | 0–20 | 0.5 (−0.5 to 1.6) | 0.29 (−0.31 to 0.89) |
| Secondary outcome measures | |||||||
| General Self-Efficacy Scale (GSES) | 31.6 (5.6) n=31 | 33.6 (5.1) n=27 | 30.5 (7.8) n=19 | 33.7 (7.0) n=22 | 10–40 | 1.3 (−2.5 to 5.0) | 0.20 (−0.42 to 0.81) |
| Hospital Anxiety and Depression Scale (HADS) | 12.8 (9.0) n=31 | 11.0 (4.8) n=24 | 11.0 (8.2) n=22 | 8.7 (6.0) n=20 | 0–42 | −1.2 (−4.8 to 2.6) | 0.20 (−0.41 to 0.81) |
| Nottingham Extended Activities of Daily Living (NEADL) | 16.1 (5.5) n=29 | 13.7 (7.4) n=27 | 14.2 (5.7) n=20 | 15.8 (6.0) n=20 | 0–22 | 3.0 (−0.4 to 6.4) | 0.63 (−0.01 to 1.26) |
| Visual Analogue Scale (VAS) for hip pain intensity | 4.2 (2.4) n=32 | 4.1 (2.3) n=28 | 3.4 (3.1) n=23 | 2.9 (2.9) n=25 | 0–10 | −0.2 (−1.7 to 1.3) | 0.00 (−0.58 to 0.58) |
| Carer outcome measure | |||||||
| Carer strain index (CSI) | 2.6 (3.1) n=12 | 3.5 (3.4) n=16 | 3.3 (3.7) n=8 | 2.7 (2.1) n=7 | 0–13 | −1 (−5.1 to 3.0) | 0.35 (−0.68 to 1.37) |
| Physical function tests | |||||||
| Grip strength | 21.0 (10.1) n=30 | 20.0 (7.2) n=26 | 23.4 (12.3) n=17 | 19.5 (8.3) n=12 | Unlimited | 1.2 (−1.7 to 4.2) | 0.35 (−0.40 to 1.09) |
Bold typeface denotes medium effect size.